Defining Compensable Injury in Biomedical Research.

Area of Science:

• Biomedical research ethics
• Public health policy
• Legal frameworks for research participants

Background:

• Biomedical research relies on human subjects, with inherent risks of unintended harm.
• Current compensation for injured participants in the U.S. relies on the "litigation lottery" of the tort system, often leaving them uncompensated.
• The U.S. is an international outlier regarding compensation for research-related injuries, despite decades of calls for a no-fault system.

Purpose of the Study:

• To establish a coherent ethical basis for compensating research-related injuries.
• To define "compensable injury" within the biomedical research context.
• To advocate for a novel no-fault compensation system in the United States.

Main Methods:

• Analysis of existing compensation systems to identify key definitional elements of "compensable injury."
• Examination of ethical justifications for compensation, focusing on retrospective nonmaleficence, distributive justice, and compensatory justice.
• Development of a tailored definition of "compensable injury" using regulatory elements and ethical justifications.

Main Results:

• Identified four essential definitional elements for "compensable injury."
• Established retrospective nonmaleficence and distributive/compensatory justice as persuasive ethical bases for compensation.
• Formulated a comprehensive definition of "compensable injury" specific to biomedical research.

Conclusions:

• A clear definition of "compensable injury" is crucial for establishing a no-fault compensation system.
• The proposed definition and ethical framework support the creation of a no-fault compensation system for research participants.
• Implementing such a system would address current inequities and align the U.S. with international best practices.